Home

miscellaneo pizzico Secondo grado lancet clinical picture Quale sensibilità Laltro giorno

Effect of early treatment with fluvoxamine on risk of emergency care and  hospitalisation among patients with COVID-19: the TOGETHER randomised,  platform clinical trial - The Lancet Global Health
Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial - The Lancet Global Health

Clinical characteristics with inflammation profiling of long COVID and  association with 1-year recovery following hospitalisation in the UK: a  prospective observational study - The Lancet Respiratory Medicine
Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study - The Lancet Respiratory Medicine

Graphical abstracts
Graphical abstracts

The Lancet Handbook of Essential Concepts in Clinical Research (The Lancet  Handbooks): Schulz PhD MBA, Kenneth, Grimes MD, David A.: 9780080448664:  Amazon.com: Books
The Lancet Handbook of Essential Concepts in Clinical Research (The Lancet Handbooks): Schulz PhD MBA, Kenneth, Grimes MD, David A.: 9780080448664: Amazon.com: Books

Cabozantinib for radioiodine-refractory differentiated thyroid cancer  (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3 trial  - The Lancet Oncology
Cabozantinib for radioiodine-refractory differentiated thyroid cancer (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet Oncology

Scabies outbreaks in ten care homes for elderly people: a prospective study  of clinical features, epidemiology, and treatment outcomes - The Lancet  Infectious Diseases
Scabies outbreaks in ten care homes for elderly people: a prospective study of clinical features, epidemiology, and treatment outcomes - The Lancet Infectious Diseases

A single dose of SARS-CoV-2 FINLAY-FR-1A vaccine enhances neutralization  response in COVID-19 convalescents, with a very good safety profile: An  open-label phase 1 clinical trial - The Lancet Regional Health – Americas
A single dose of SARS-CoV-2 FINLAY-FR-1A vaccine enhances neutralization response in COVID-19 convalescents, with a very good safety profile: An open-label phase 1 clinical trial - The Lancet Regional Health – Americas

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2  vaccine (CoronaVac) in healthy children and adolescents: a double-blind,  randomised, controlled, phase 1/2 clinical trial - The Lancet Infectious  Diseases
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial - The Lancet Infectious Diseases

Safety, tolerability, and immunogenicity of the respiratory syncytial virus  prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label,  dose-escalation clinical trial - The Lancet Respiratory Medicine
Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial - The Lancet Respiratory Medicine

Etrolizumab for ulcerative colitis: beyond what meets the eye - The Lancet  Gastroenterology & Hepatology
Etrolizumab for ulcerative colitis: beyond what meets the eye - The Lancet Gastroenterology & Hepatology

Patient-reported wellbeing and clinical disease measures over time captured  by multivariate trajectories of disease activity in individuals with  juvenile idiopathic arthritis in the UK: a multicentre prospective  longitudinal study - The Lancet
Patient-reported wellbeing and clinical disease measures over time captured by multivariate trajectories of disease activity in individuals with juvenile idiopathic arthritis in the UK: a multicentre prospective longitudinal study - The Lancet

The Lancet Commission on the future of care and clinical research in autism  - The Lancet
The Lancet Commission on the future of care and clinical research in autism - The Lancet

Adjustable intragastric balloon for treatment of obesity: a multicentre,  open-label, randomised clinical trial - The Lancet
Adjustable intragastric balloon for treatment of obesity: a multicentre, open-label, randomised clinical trial - The Lancet

Interleukin-6 receptor blockade in patients with COVID-19: placing clinical  trials into context - The Lancet Respiratory Medicine
Interleukin-6 receptor blockade in patients with COVID-19: placing clinical trials into context - The Lancet Respiratory Medicine

A clinical prediction rule for ambulation outcomes after traumatic spinal  cord injury: a longitudinal cohort study - The Lancet
A clinical prediction rule for ambulation outcomes after traumatic spinal cord injury: a longitudinal cohort study - The Lancet

Clinical and virological data of the first cases of COVID-19 in Europe: a  case series - The Lancet Infectious Diseases
Clinical and virological data of the first cases of COVID-19 in Europe: a case series - The Lancet Infectious Diseases

Neuropsychiatric safety and efficacy of varenicline, bupropion, and  nicotine patch in smokers with and without psychiatric disorders (EAGLES):  a double-blind, randomised, placebo-controlled clinical trial - The Lancet
Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial - The Lancet

Prognostic value of patient-reported outcomes from international randomised  clinical trials on cancer: a systematic review - The Lancet Oncology
Prognostic value of patient-reported outcomes from international randomised clinical trials on cancer: a systematic review - The Lancet Oncology

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2  vaccine in healthy adults aged 18–59 years: a randomised, double-blind,  placebo-controlled, phase 1/2 clinical trial - The Lancet Infectious  Diseases
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial - The Lancet Infectious Diseases

Linking interdisciplinary and multiscale approaches to improve healthspan—a  new UK model for collaborative research networks in ageing biology and  clinical translation - The Lancet Healthy Longevity
Linking interdisciplinary and multiscale approaches to improve healthspan—a new UK model for collaborative research networks in ageing biology and clinical translation - The Lancet Healthy Longevity

Prevalence, risk factors, outcomes, and molecular epidemiology of  mcr-1-positive Enterobacteriaceae in patients and healthy adults from  China: an epidemiological and clinical study - The Lancet Infectious  Diseases
Prevalence, risk factors, outcomes, and molecular epidemiology of mcr-1-positive Enterobacteriaceae in patients and healthy adults from China: an epidemiological and clinical study - The Lancet Infectious Diseases

Lancet eBooks
Lancet eBooks

Major depressive disorder: new clinical, neurobiological, and treatment  perspectives - The Lancet
Major depressive disorder: new clinical, neurobiological, and treatment perspectives - The Lancet